Hubei Goto Biopharm Co.Ltd. (300966)
Shenzhen Stock Exchange · China · prices in CNY · close of 22 Oct 2026
Key indicators
| Last close | CNY 23.08 |
|---|---|
| 52-week range | 18.44 – 32.58 |
| Return, 1 month / 3 months | −11.0% / +6.8% |
| Return, 1 year / 3 years | +2.6% / +10.5% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 45.0% |
| Worst drawdown (1 year) | -31.4% |
| Average daily value traded | 64.29M CNY |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Hubei Goto Biopharm Co.Ltd. (300966) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 23.08 on 22 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 574 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.6% and over the last three months it rose 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -3.2% | ||
| From 52-week high | -25.7% | ||
| Momentum | 78 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 6.8% | ||
| 6-month return | 6.0% | ||
| 12-month return, skipping the last month | 15.2% | ||
| Stability (higher is calmer) | 73 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.4% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 64.29M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 10 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.1% |
|---|---|
| 1 month | −11.0% |
| 3 months | +6.8% |
| 6 months | +6.0% |
| 1 year | +2.6% |
| 3 years | +10.5% |
| 5 years | −37.7% |
Signals
| 50-day / 200-day average | 24.70 / 23.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jul 2026 | CNY 0.0450 |
| 12 Jun 2024 | CNY 0.0160 |
| 31 May 2022 | CNY 0.1360 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.